ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Zylox-Tonbridge Medical Technology Co., Ltd. Stock
Equities
2190
CNE100004JD2
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.4 HKD | +1.17% |
|
-6.31% | -16.40% |
| May. 09 | Zylox-Tonbridge Medical Technology Co., Ltd. Announces Retirement of Hongze Liang as an Independent Non-Executive Director | CI |
| Mar. 22 | Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 | MT |
| Sales 2024 * | 760M 105M 819M | Sales 2025 * | 1.08B 149M 1.17B | Capitalization | 3.09B 426M 3.33B |
|---|---|---|---|---|---|
| Net income 2024 * | 72M 9.94M 77.61M | Net income 2025 * | 161M 22.22M 174M | EV / Sales 2024 * | 3.01 x |
| Net cash position 2024 * | 802M 111M 864M | Net cash position 2025 * | 800M 110M 862M | EV / Sales 2025 * | 2.12 x |
| P/E ratio 2024 * |
43.3
x | P/E ratio 2025 * |
19.6
x | Employees | 765 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 32.53% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.17% | ||
| 1 week | -6.31% | ||
| Current month | -0.76% | ||
| 1 month | -0.95% | ||
| 3 months | +4.00% | ||
| 6 months | -10.65% | ||
| Current year | -16.40% |
1 week
10.06
11.32
1 month
10.0211.36
Current year
8.6212.58
1 year
7.2014.66
3 years
7.2060.80
5 years
7.2060.80
10 years
7.2060.80
| Managers | Title | Age | Since |
|---|---|---|---|
Zhong Zhao
CEO | Chief Executive Officer | 57 | 12-11-05 |
Quan Wei Yuan
DFI | Director of Finance/CFO | 46 | 20-12-31 |
Ning Pan
CTO | Chief Tech/Sci/R&D Officer | 58 | 18-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong Ze Liang
BRD | Director/Board Member | 53 | 21-03-01 |
Hui Wang
BRD | Director/Board Member | 51 | 15-10-31 |
Da Song Wang
BRD | Director/Board Member | 55 | 20-10-12 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 10.4 | +1.17% | 77 500 |
| 24-05-23 | 10.28 | +1.18% | 126,000 |
| 24-05-22 | 10.16 | -1.17% | 118,500 |
| 24-05-21 | 10.28 | -4.46% | 211,500 |
| 24-05-20 | 10.76 | -3.06% | 67,000 |
Delayed Quote Hong Kong S.E., May 23, 2024 at 11:28 pm EDT
More quotes
Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic and foreign markets.
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.534
CNY
Average target price
14.14
CNY
Spread / Average Target
+48.33%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.40% | 422M | |
| +10.24% | 128B | |
| -8.89% | 11.26B | |
| +3.31% | 9.28B | |
| +35.16% | 5.42B | |
| -23.90% | 4.8B | |
| +8.20% | 3.45B | |
| -10.69% | 2.8B | |
| -12.15% | 2.1B | |
| -11.96% | 1.98B |
- Stock Market
- Equities
- 2190 Stock
